In univariate analysis, higher baseline serum neuron-specific enolase (NSE) levels showed a trend toward shorter PFS, although this did not reach statistical significance.
← all excerpts
Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors.
2
—
—
The sentences
Patients with elevated baseline neuron-specific enolase (NSE) showed a trend toward poorer outcomes, suggesting its potential role as a prognostic biomarker.